Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 38093 versus placebo in mild to moderate Alzheimer's disease
ISRCTN89039808Phase 2Completed
- Sponsor
- Servier
- Start
- Aug 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of S-38093 in Alzheimer's disease (AD) (4 arms), sponsored by Servier. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) 11-item at week 48. Started Aug 2011; status: completed.
02
Drugs
S-38093
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ISRCTN89039808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89039808.